A
AN2 Therapeutics D
D
ANTX
1.39500
USD
-0.01
(-0.36%)
مغلق
حجم التداول
17,561
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
41,681,052
العنوان: AN2 Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.